NCT00928967View on ClinicalTrials.gov

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

November 30, 2010

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b, (Betaseron BAY86-5046)

The cohort included is described in section 8.5 (inclusion criteria)

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00928967 - Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter